The deal, financial terms of which were not disclosed, will help expand both companies' precision medicine offerings, bringing genomic insights to EHR workflows at the point of care.
AccessDx is a Texas-based biotechnology firm that provides diagnostic solutions for personalized medicine, infectious disease programs and COVID-19 testing.